Home - Lustgarten Foundation: Pancreatic Cancer Research
LustGarden Foundation for Pancreatic Cancer Research

Pancreatic Cancer Research

As the largest private funder of pancreatic cancer research, we are relentlessly focused on improving patient outcomes and we are making progress every day. Thanks to separate funding to support administrative expenses, 100 percent of every donation goes directly to research.

Navigating Pancreatic Cancer

We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.

Patient Checklist

Checklist

August 1, 2018 ladmin
As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]
Lets Win! Pancreatic Cancer

Let’s Win! Pancreatic Cancer

July 20, 2018 ladmin
LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]

Pancreatic Cancer Connections

July 7, 2018 ladmin
Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery. Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.

Lustgarten News

View All Articles

Led By Lustgarten: How Research Impacts Care

November is Pancreatic Cancer Awareness Month Join us at Noon, Tuesday, Nov. 9 for a special event: Led By Lustgarten: How Research Impacts Patient Care featuring Dr. Joseph Herman, Vice Chair of Clinical Informatics for Radiation Medicine and Director of Clinical Research Integration at Northwell Health. A nationally-recognized radation oncologist, Dr. Herman will sit down with Lustgarten CEO Linda Tantawi and VP of Research Dr. Andrew Rakeman for a live, interactive conversation on how Lustgarten-funded research informs patient treatment in the care setting. Register now to save your seat!

Learn More

Register For Lustgarten Live!

Welcome to LustgartenLIVE! a quarterly series of webinars designed to bring you face-to-face with the best researchers investigating pancreatic cancer. Moderated by Andrew Rakeman, PhD , Vice President of Research, each webinar in the series will focus on a different aspect of the research funded through your donations. REGISTRATION IS NOW OPEN for The Best of 2021: Research Highlights
The Best of 2021: Research Highlights, the final LustgartenLIVE! in the inaugural quarterly series, will stream at Noon, Tuesday, Dec. 14. LustgartenLIVE! was created to give patients, family members, donors and others an opportunity to hear directly from the lead scientists behind our most promising research projects in earlier detection, drug development and personalized medicine. And, because it’s LIVE, you’ll have an opportunity to ask them questions. The Best of 2021: Research Highlights presenters include: David Tuveson, MD, PhD Chief Scientist; Director of the Lustgarten Foundation Dedicated Research Lab at Cold Spring Harbor Laboratory (CSHL) Cancer Center; President, American Association of Cancer Research (AACR) Elizabeth Jaffee, MD Chief Medical Advisor; Director, Lustgarten Clinical Accelerator Initiative; Deputy Director of the Sidney Kimmel Comprehensive Cancer Center and Co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at the Johns Hopkins University School of Medicine Linda Tantawi CEO, Lustgarten Foundation Andrew Rakeman, PhD VP of Research, Lustgarten Foundation

Learn More

Clinical Trials Finder

If you have been diagnosed with pancreatic cancer, a clinical trial may be your best treatment option. Many clinical trials are underway for patients in all stages of the disease and may involve new combinations of currently available drugs or new drugs that have worked in other cancers. No matter where you are in your journey, we encourage you to learn more about clinical trials.

Learn More

Pancreatic Cancer News

View All Articles

Pancreatic cancer clinical trials exclude Black patients based on wide range of eligibility criteria

7. 10. 21 Glen Peck
A simulated pancreatic cancer clinical trial screening process showed that Black patients were significantly more likely than white patients to be excluded from clinical trials for a wide range of eligibility criteria, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically […]

The Power of Therapeutic Laughter

1. 10. 21 Glen Peck
When you’re facing a pancreatic cancer diagnosis, humor may be tough to come by. Instead, feelings of grief, sadness, depression and anxiety become so all-consuming that getting a chuckle from even the most hilarious prank seems like an impossibility. But here’s the thing: It turns out that laughter — whether forced or spontaneous — is […]

A Leading Surgeon Helps Patients with Pancreatic Cancer Overcome Steep Odds

1. 10. 21 Glen Peck
An internationally renowned pancreatic surgeon, surgical oncologist, and cancer researcher, Christopher Wolfgang, MD, PhD, joined NYU Langone Health last January. He is chief of the new Division of Hepatobiliary and Pancreatic Surgery in the Department of Surgery, having previously served as chief of hepatobiliary and pancreatic surgery and vice chair for surgical oncology at Johns […]

Pancreatic Cancer Research Ramps Up as Roche and NovoCure Announce Partnership

1. 10. 21 Glen Peck
Pancreatic cancer has the lowest survival rate of the most common cancers, less than 10% of patients survive longer than five years, largely due to most cases being diagnosed at a late stage. A collaboration between NovoCure and Roche hopes to improve those odds. This morning, NovoCure and Swiss pharma giant Roche announced a collaboration […]

Unique Aspects of Pancreatic Cancer Proteins Could Lead to Early Detection, New Treatments

1. 10. 21 Glen Peck
Newswise — A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins. Their findings, published online Sept. 16 in Cell, could offer hope to patients with this deadly disease. […]

13 Warning Signs of Pancreatic Cancer You Should Know, Doctors Say

1. 10. 21 Glen Peck
Pancreatic cancer is tricky to identify. In the early stages, there might not be much—if any—indication something is even wrong, and that’s exactly why doctors often refer to it as a “silent killer.” Most recently, the deadly disease took the life of actor Willie Garson. Best known for his role as Stanford Blatch on Sex […]

Why Identical Genetic Mutations Cause Different Types of Cancer

19. 7. 21 ladmin
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium (DKTK), the Technical University of Munich (TUM), and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same […]

Matchmakers: How Basket Trials Match Patients With Drugs Based on Their Tumors

14. 7. 21 ladmin
Drew Huggins was running out of options. After his diagnosis of metastatic pancreatic cancer two years ago, at age 47, he hadn’t had any luck with the treatments he’d tried so far. His tumors didn’t respond to 13 cycles of FOLFIRINOX, an arduous four-drug chemotherapy combination. The chemo- therapy combination of gemcitabine and paclitaxel didn’t […]

Immune cells assemble – boosting the effects of chemotherapy in pancreatic cancer

9. 7. 21 ladmin
A new study from Queen Mary University of London has demonstrated that immune cells can be stimulated to assemble into special structures within pancreatic cancer such that, at least in a pre-clinical model, researchers can demonstrate an improvement in the efficacy of chemotherapy. The body’s immune system is a critical defence against illness such as […]

Join Us

Get Involved Today

Get inspired and connect with patients, survivors and loved ones who are all on the same journey.

Back to Top